UTILIZATION AND MORTALITY TRENDS FOR BALLOON MITRAL VALVULOPLASTY IN THE UNITED STATES: AN EIGHT–YEAR PERSPECTIVE  by Ghatak, Abhijit et al.
Valvular Heart Disease
E2008
JACC March 12, 2013
Volume 61, Issue 10
uTilizaTion and morTaliTy Trends for Balloon miTral valvuloplasTy in The uniTed sTaTes: 
an eighT-year perspecTive
Moderated Poster Contributions
Poster Sessions, Expo North
Monday, March 11, 2013, 9:45 a.m.-10:30 a.m.
Session Title: Valvular Heart Disease: Clinical VII - Mitral Valve
Abstract Category: 31. Valvular Heart Disease: Clinical
Presentation Number: 1285M-83
Authors: Abhijit Ghatak, Nileshkumar Patel, Kathan Mehta, Ankit Chothani, Abhishek Deshmukh, Neeraj Shah, Vikas Singh, Peeyush Grover, Ankit 
Rathod, George Marzouka, Ghanshyam Savani, Rajeev Sudhakar, Sidak Panaich, Tushar Tuliani, Apurva Badheka, Mauricio Cohen, William O’Neill, 
Eduardo De Marchena, University of Miami Miller School of Medicine, Miami, FL, USA, Staten Island University Hospital, Staten Island, NY
Background: Incidence of rheumatic mitral stenosis had steadily decreased in developed countries like USA. The cross sectional data investigating 
Balloon Mitral Valvuloplasty (BMV) use in the USA is lacking.
methods: We queried the Healthcare Cost and Utilization Project’s Nationwide Inpatient Sample (NIS) between 2003 and 2010 using the 
ICD9 procedure code of 35.96 for valvuloplasty. Only patients ≥18 years of age with mitral stenosis were included. Patients with concomitant 
aortic,tricuspid or pulmonic stenosis were excluded. Census data was used for population estimates of all adults ≥18 years of age to calculate time 
trends in utilization rate. We defined severity of comorbidities using Charlson index (CCI), where higher scores (0-33) represent increasing burden.
results: The utilization rates of BMV has significantly decreased from 11.4 BMV/million population in 2003-2004 to 7.5 BMV/million population 
in 2009-2010 (p<0.001). There was a trend towards increased inhospital mortality associated with BMV from 2.3% in 2003-2004 to 4.3% in 2009-
2010 (p=0.06). For any given year, females (74.79%) had the maximum number of procedures. Increasing CCI was associated with higher in-hospital 
mortality (HR 1.56, 95% CI 1.40-1.75, p<0.001).
conclusions: The decrease in utilization rate for BMV reflects the decrease in the incidence of rheumatic mitral valve stenosis over the last 
decade. This is the first study reporting the utilization and mortality rate for BMV in USA.
 
